Catherine Stehman‐Breen

13.1k total citations · 3 hit papers
75 papers, 10.0k citations indexed

About

Catherine Stehman‐Breen is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Catherine Stehman‐Breen has authored 75 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Nephrology, 18 papers in Pulmonary and Respiratory Medicine and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Catherine Stehman‐Breen's work include Dialysis and Renal Disease Management (30 papers), Chronic Kidney Disease and Diabetes (22 papers) and Parathyroid Disorders and Treatments (15 papers). Catherine Stehman‐Breen is often cited by papers focused on Dialysis and Renal Disease Management (30 papers), Chronic Kidney Disease and Diabetes (22 papers) and Parathyroid Disorders and Treatments (15 papers). Catherine Stehman‐Breen collaborates with scholars based in United States, Canada and Australia. Catherine Stehman‐Breen's co-authors include Daniel L. Gillen, Stephen L. Seliger, Michael G. Shlipak, Linda F. Fried, Anne B. Newman, David S. Siscovick, Donald J. Sherrard, Ronit Katz, Bryan Kestenbaum and Mark J. Sarnak and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Catherine Stehman‐Breen

75 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons

2005 980 citations Michael G. Shlipak, Mark J. Sarnak et al. profile →
Increased risk of hip fracture among patients with end-stage renal disease

2000 655 citations Donald J. Sherrard, Daniel L. Gillen et al. Kidney International profile →
Cardiovascular Mortality Risk in Chronic Kidney Disease

2005 537 citations Michael G. Shlipak, Linda F. Fried et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Stehman‐Breen United States	49	6.1k	2.1k	1.7k	1.5k	1.2k	75	10.0k
Takashi Akiba Japan	50	6.6k 1.1×	1.1k 0.5×	1.6k 0.9×	1.7k 1.1×	372 0.3×	252	10.3k
Kosaku Nitta Japan	46	7.6k 1.2×	3.0k 1.4×	2.6k 1.5×	2.3k 1.5×	423 0.4×	598	14.8k
Kunitoshi Iseki Japan	58	8.4k 1.4×	2.9k 1.4×	1.5k 0.9×	2.2k 1.5×	286 0.2×	321	13.1k
Isidro B. Salusky United States	52	7.8k 1.3×	477 0.2×	1.6k 0.9×	1.5k 1.0×	954 0.8×	250	10.9k
Marc Vervloet Netherlands	43	4.5k 0.7×	531 0.3×	1.1k 0.6×	962 0.6×	612 0.5×	189	6.7k
Juan Bosch United States	2	5.5k 0.9×	3.5k 1.7×	2.3k 1.4×	2.1k 1.3×	194 0.2×	3	12.6k
Stephen L. Seliger United States	53	6.0k 1.0×	4.5k 2.2×	2.1k 1.2×	1.7k 1.1×	226 0.2×	177	12.5k
Maarten W. Taal United Kingdom	45	3.4k 0.6×	1.5k 0.7×	907 0.5×	947 0.6×	192 0.2×	203	6.6k
Orlando M. Gutiérrez United States	48	6.9k 1.1×	1.1k 0.5×	1000 0.6×	1.3k 0.8×	535 0.5×	203	10.4k
Tamara Isakova United States	44	8.5k 1.4×	863 0.4×	1.2k 0.7×	1.6k 1.0×	341 0.3×	145	11.2k

Countries citing papers authored by Catherine Stehman‐Breen

Since Specialization

Citations

This map shows the geographic impact of Catherine Stehman‐Breen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Stehman‐Breen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Stehman‐Breen more than expected).

Fields of papers citing papers by Catherine Stehman‐Breen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Stehman‐Breen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Stehman‐Breen. The network helps show where Catherine Stehman‐Breen may publish in the future.

Co-authorship network of co-authors of Catherine Stehman‐Breen

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Stehman‐Breen. A scholar is included among the top collaborators of Catherine Stehman‐Breen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Stehman‐Breen. Catherine Stehman‐Breen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ix, Joachim H., Ronit Katz, Bryan Kestenbaum, et al.. (2008). Association of Mild to Moderate Kidney Dysfunction and Coronary Calcification. Journal of the American Society of Nephrology. 19(3). 579–585. 52 indexed citations

Seliger, Stephen L., W.T. Longstreth, Ronit Katz, et al.. (2005). Cystatin C and Subclinical Brain Infarction. Journal of the American Society of Nephrology. 16(12). 3721–3727. 106 indexed citations

Fried, Linda F., Ronit Katz, Mark J. Sarnak, et al.. (2005). Kidney Function as a Predictor of Noncardiovascular Mortality. Journal of the American Society of Nephrology. 16(12). 3728–3735. 231 indexed citations

O’Hare, Ann M., Anne B. Newman, Ronit Katz, et al.. (2005). Cystatin C and Incident Peripheral Arterial Disease Events in the Elderly. Archives of Internal Medicine. 165(22). 2666–2666. 68 indexed citations

Shlipak, Michael G., Mark J. Sarnak, Ronit Katz, et al.. (2005). Cystatin-C and mortality in elderly persons with heart failure. Journal of the American College of Cardiology. 45(2). 268–271. 167 indexed citations

Cunningham, John, Stuart M. Sprague, Jorge B. Cannata‐Andía, et al.. (2004). Osteoporosis in chronic kidney disease. American Journal of Kidney Diseases. 43(3). 566–571. 152 indexed citations

Kestenbaum, Bryan, Dennis L. Andress, Stephen M. Schwartz, et al.. (2004). Survival following parathyroidectomy among United States dialysis patients. Kidney International. 66(5). 2010–2016. 185 indexed citations

Wasse, Haimanot, Daniel L. Gillen, Adrianne Ball, et al.. (2003). Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. Kidney International. 64(4). 1455–1461. 115 indexed citations

Stehman‐Breen, Catherine, Gail D. Anderson, Debbie Gibson, Annamaria T. Kausz, & Susan M. Ott. (2003). Pharmacokinetics of oral micronized β-estradiol in postmenopausal women receiving maintenance hemodialysis. Kidney International. 64(1). 290–294. 17 indexed citations

10.

Meyers, Catherine M., Leonard B. Seeff, Catherine Stehman‐Breen, & Jay H. Hoofnagle. (2003). Hepatitis C and renal disease: an update. American Journal of Kidney Diseases. 42(4). 631–657. 265 indexed citations

11.

Seliger, Stephen L., Daniel L. Gillen, David Tirschwell, et al.. (2003). Risk Factors for Incident Stroke among Patients with End-Stage Renal Disease. Journal of the American Society of Nephrology. 14(10). 2623–2631. 129 indexed citations

12.

Wong, Craig S., Sangeeta Hingorani, Daniel L. Gillen, et al.. (2002). Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney International. 61(2). 630–637. 105 indexed citations

13.

Seliger, Stephen L., Noel S. Weiss, Daniel L. Gillen, et al.. (2002). HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney International. 61(1). 297–304. 225 indexed citations

14.

Mazhar, A., Richard J. Johnson, Daniel L. Gillen, et al.. (2001). Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney International. 60(1). 324–332. 259 indexed citations

15.

Stehman‐Breen, Catherine, Leslie Miller, Jeffrey C. Fink, & Stephen M. Schwartz. (2000). Pre‐eclampsia and premature labour among pregnant women with haematuria. Paediatric and Perinatal Epidemiology. 14(2). 136–140. 7 indexed citations

16.

Stehman‐Breen, Catherine, Donald J. Sherrard, Daniel L. Gillen, & Michael Caps. (2000). Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney International. 57(2). 639–645. 178 indexed citations

17.

Stehman‐Breen, Catherine, Donald J. Sherrard, Daniel L. Gillen, et al.. (2000). Risk factors for hip fracture among patients with end-stage renal disease. Kidney International. 58(5). 2200–2205. 260 indexed citations

18.

Stehman‐Breen, Catherine, Daniel L. Gillen, & Debbie S. Gipson. (1999). Prescription of hormone replacement therapy in postmenopausal women with renal failure. Kidney International. 56(6). 2243–2247. 29 indexed citations

19.

Stehman‐Breen, Catherine, Bruce M. Psaty, Scott S. Emerson, et al.. (1997). ASSOCIATION OF HEPATITIS C VIRUS INFECTION WITH MORTALITY AND GRAFT SURVIVAL IN KIDNEY-PANCREAS TRANSPLANT RECIPIENTS. Transplantation. 64(2). 281–286. 33 indexed citations

20.

Stehman‐Breen, Catherine, Richard A. Willson, Charles E. Alpers, David R. Gretch, & Richard J. Johnson. (1995). Hepatitis C virus-associated glomerulonephritis. Current Opinion in Nephrology & Hypertension. 4(3). 287–294. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact